text
"['\n3. 타법인출자 현황(상세)\n☞ 본문 위치로 이동\n(기준일 :\xa0\n2021년 06월 30일\n)\n(단위 : 백만원, 천주, %)\n법인명\n상장여부\n최초취득일자\n출자목적\n최초취득금액\n기초잔액\n증가(감소)\n기말잔액\n최근사업연도재무현황\n수량\n지분율\n장부가액\n취득(처분)\n평가손익\n수량\n지분율\n장부가액\n총자산\n당기순손익\n수량\n금액\n대신경제연구소\n비상장\n1984.09.17\n투자\n4,950\n495\n99\n4,950\n-\n-\n-\n495\n99\n4,950\n6,245\n310\n대신자산운용\n비상장\n1988.06.10\n투자\n67,909\n5,800\n100\n35,504\n-\n-\n-\n5,800\n100\n35,504\n41,916\n3,038\n대신저축은행\n비상장\n2011.08.05\n투자\n130,000\n7,120\n100\n130,000\n-\n-\n-\n7,120\n100\n130,000\n1,721,042\n16,084\n대신에프앤아이\n비상장\n2014.05.07\n투자\n368,480\n14,000\n100\n368,480\n-\n-\n-\n14,000\n100\n368,480\n1,964,742\n18,577\n대신프라이빗에쿼티\n비상장\n2012.09.27\n투자\n10,000\n2,000\n100\n10,000\n-\n-\n-\n2,000\n100\n10,000\n13,993\n659\n대신인베스트먼트PTE\xa0\n비상장\n2017.08.29\n투자\n101\n735\n100\n595\n-\n-\n-\n735\n100\n595\n869\n80\n대신아메리카LLC\n비상장\n2018.06.14\n투자\n46,229\n-\n100\n46,229\n-\n14,128\n-\n-\n100\n60,357\n541,692\n-6,574\n대신자산신탁\n비상장\n2019.05.30\n투자\n100,000\n20,000\n100\n100,000\n2,000\n50,000\n-\n22,000\n100\n150,000\n102,850\n530\nDaishin Tokyo Godo Kaisha\n비상장\n2020.06.23\n투자\n10,211\n-\n100\n10,211\n-\n21,583\n-\n-\n100\n31,794\n9,775\n-228\n케이아이디비 채권중개\n비상장\n2000.05.23\n투자\n380\n76\n6\n380\n-\n-\n-\n76\n6\n380\n16,896\n801\n한국증권금융\n비상장\n1981.01.31\n투자\n14,780\n5,741\n4\n80,162\n-\n-\n-625\n5,741\n4\n79,537\n60,979,300\n262,031\n코스콤\n비상장\n1978.04.20\n투자\n291\n58\n1\n5,132\n-\n-\n25\n58\n1\n5,157\n531,762\n38,300\n한국예탁결제원\n비상장\n1994.03.18\n투자\n1,027\n215\n2\n20,558\n-\n-\n123\n215\n2\n20,681\n5,013,507\n97,776\n한국거래소\n비상장\n2005.03.28\n투자\n3,210\n645\n3\n131,439\n-\n-\n11,144\n645\n3\n142,583\n8,326,400\n177,700\n한국자금중개\n비상장\n1996.07.15\n투자\n50\n10\n1\n707\n-\n-\n41\n10\n1\n748\n102,722\n9,103\n여의시스템\n비상장\n2008.05.02\n투자\n490\n196\n4\n490\n-\n-\n-\n196\n4\n490\n33,359\n2,972\n마이크로사이언스테크\n비상장\n2000.03.21\n투자\n721\n221\n13\n247\n-\n-\n-\n221\n13\n247\n1,477\n26\n트윔\n비상장\n2017.10.31\n투자\n1,992\n97\n2\n1,992\n-\n-\n-\n97\n2\n1,992\n52,626\n2,540\n존스미디어\n비상장\n2018.01.16\n투자\n1,000\n25\n3\n1,000\n-\n-\n-\n25\n3\n1,000\n42,163\n-3,604\n엔드림\n비상장\n2018.06.08\n투자\n1,000\n312\n-\n1,000\n-\n-\n-\n312\n-\n1,000\n154,843\n18,353\n오티디코퍼레이션\n비상장\n2018.06.15\n투자\n1,496\n-\n2\n1,496\n-\n-\n-\n-\n2\n1,496\n47,691\n-34,317\n바이젠셀\n비상장\n2018.07.27\n투자\n1,000\n5\n2\n1,000\n-\n-\n-\n5\n2\n1,000\n23,050\n-10,455\n버드뷰\n비상장\n2018.08.02\n투자\n1,000\n1\n2\n1,000\n-\n-\n-\n1\n2\n1,000\n10,641\n-566\n브릿지바이오테라퓨틱스\n상장\n2019.12.20\n의무인수\n700\n10\n-\n196\n-\n-\n-\n10\n-\n196\n63,510\n-19,232\n바이오다인\n상장\n2020.02.21\n투자\n1,000\n83\n1\n1,000\n-78\n-1,000\n-\n5\n-\n-\n25,245\n-4,454\n코리아바이오컴페니언1호\n-\n2020.03.26\n투자\n500\n-\n-\n500\n-\n-\n-\n-\n-\n500\n158,912\n3,750\n청담글로벓\n비상장\n2020.08.31\n투자\n1,000\n-\n-\n1,000\n-\n-\n-\n-\n-\n1,000\n25,933\n3,260\n피에이치파마\n비상장\n2020.09.28\n투자\n500\n24\n-\n500\n-\n-\n-\n24\n-\n500\n18,216\n-18,641\n플레로게임즈\n비상장\n2020.12.24\n투자\n1,000\n16\n1\n1,000\n-\n-\n-\n16\n1\n1,000\n16,826\n1,087\n2020 SBI스케일업펀드\n-\n2021.02.24\n투자\n350\n-\n-\n-\n-\n600\n-\n-\n-\n600\n-\n-\nSGI유니콘스타트업투자조합\n-\n2021.02.26\n투자\n1,000\n-\n-\n-\n-\n1,000\n-\n-\n-\n1,000\n-\n-\n티그리스유온투자조합3호\n-\n2021.04.05\n투자\n1,000\n-\n-\n-\n-\n1,000\n-\n-\n-\n1,000\n-\n-\n메디컬아이피\n비상장\n2021.05.03\n투자\n500\n-\n-\n-\n-\n500\n-\n-\n-\n500\n3,811\n-7,165\n샘씨엔에스\n상장\n2021.05.20\n의무인수\n1,000\n153\n-\n1,000\n-\n-\n-\n153\n-\n1,000\n46,716\n6,034\n이뮨메드\n비상장\n2018.02.09\n투자\n1,000\n27\n1\n1,000\n-\n-\n-\n27\n1\n1,000\n9,248\n-17,650\n애드바이오텍\n상장\n2019.03.18\n투자\xa0\n500\n45\n2\n500\n91\n-\n-\n137\n2\n500\n11,417\n45\n엑소스템텍\n비상장\n2020.06.05\n투자\n500\n25\n1\n500\n-\n-\n-\n25\n1\n500\n4,685\n-2,652\n일리아스바이오로직스\n비상장\n2020.08.25\n투자\n1,000\n50\n-\n1000\n-\n-\n-\n50\n-\n1,000\n29,668\n-9,937\n비나텍\n상장\n2020.09.23\n의무인수\n594\n18\n-\n594\n-18\n-766\n172\n-\n-\n-\n85,529\n3,174\n고바이오랩\n상장\n2020.11.18\n의무인수\n450\n30\n-\n450\n-30\n-1,163\n713\n-\n-\n-\n55,675\n-56,315\n클리노믹스\n상장\n2020.12.04\n의무인수\n822\n59\n-\n822\n-59\n-823\n1\n-\n-\n-\n45,245\n-12,107\n핑거\n상장\n2021.01.29\n의무인수\n624\n-\n-\n-\n-\n-190\n190\n-\n-\n-\n35,536\n2,867\n레인보우로보틱스\n상장\n2021.02.03\n의무인수\n397\n-\n-\n-\n-\n-480\n480\n-\n-\n-\n11,404\n-1,406\n핀텔\n비상장\n2021.03.05\n투자\n500\n-\n-\n-\n-\n500\n-\n-\n-\n500\n2,445\n-24\n엑셀세라퓨틱스\n비상장\n2021.03.17\n투자\n500\n-\n-\n-\n28\n500\n-\n28\n-\n500\n14,044\n-10,106\n제주맥주\n상장\n2021.05.26\n의무인수\n802\n-\n-\n-\n205\n802\n-\n205\n-\n802\n62,889\n-10,611\n을지로나인피에프브이\n비상장\n2020.03.26\n투자\n250\n50\n5\n250\n-\n-\n-\n50\n5\n250\n10,167\n-2,182\n넥스트브이시티피에프브이\n비상장\n2020.10.19\n투자\n700\n140\n14\n700\n-\n-\n-\n140\n14\n700\n34,730\n-270\n캡스톤전문투자형사모부동산투자신탁29호\n비상장\n2021.03.30\n투자\n3,000\n-\n-\n-\n3,000\n3,000\n-\n3,000\n4\n3,000\n-\n-\n진위3산단\n비상장\n2016.05.13\n투자\n250\n50\n5\n250\n-\n-\n-\n50\n5\n250\n50,409\n147\n신영피에프브이제2호\n비상장\n2019.06.25\n투자\n250\n50\n5\n250\n-\n-\n-\n50\n5\n250\n16,662\n15,101\n인트러스장안피에프브이\n비상장\n2021.04.27\n투자\n2,000\n-\n-\n-\n400\n2,000\n-\n400\n11\n2,000\n-\n-\n광주방송\n비상장\n2013.07.08\n투자\n5,602\n65\xa0\n8\n6,104\n-\n-\n-\n656\xa0\n8\xa0\n6,104\n145,912\n6,229\n과천피에프브이\n비상장\n2017.04.28\n투자\n1,000\n50\n5\n1,000\n-\n-\n-\n50\n5\n1,000\n116,442\n-6,708\n대신신기술투자조합제2호\n-\n2019.05.10\n투자\n500\n-\n2\n334\n-\n-120\n-214\n-\n-\n-\n28,610\n2,831\n대신-K&T신기술투자조합\n-\n2019.06.28\n투자\n200\n200,000\n1\n200\n-\n-\n41\n200,000\n1\n241\n39,649\n-2,011\n대신신기술투자조합제3호\n-\n2019.07.26\n투자\n300\n-\n3\n178\n-\n-\n84\n-\n3\n262\n9,378\n1,394\n대신신기술투자조합제4호\n-\n2019.07.30\n투자\n100\n100,000\n7\n100\n-\n-\n-\n100,000\n7\n100\n1,416\n-24\n대신신기술투자조합제5호\n-\n2020.10.12\n투자\n300\n-\n2\n309\n-\n-\n17\n-\n2\n326\n12,164\n-40\n대신-KNT-다석신기술투자조합\n-\n2021.01.14\n투자\n200\n-\n-\n-\n-\n200\n-\n-\n4\n200\n-\n-\n대신-MYW신기술투자조합\n-\n2021.02.09\n투자\n4,800\n-\n-\n-\n-\n4,790\n817\n-\n5\n5,607\n-\n-\n대신신기술투자조합제6호\n-\n2021.04.01\n투자\n500\n-\n-\n-\n-\n500\n-59\n-\n10\n441\n-\n-\n에이티유이스포츠그로쓰1호 PEF\n-\n2019.12.23\n투자\n2,000\n2\n10\n1,947\n-\n-\n-\n2\n10\n1,947\n19,672\n441\nDMW San Jose LLC\n비상장\n2017.12.29\n투자\n\xa0 \xa0 \xa0 \xa0 5,143\n-\n\xa0 \xa0 \xa0 \xa0 \xa0 \xa0 33\n\xa0 \xa0 \xa0 \xa0 5,143\n-\n-\n-\n-\n\xa0 \xa0 \xa0\xa0 33\n\xa0 \xa0 \xa0 \xa0 5,143\n13,156\n-2,398\nDaishin NY LLC\n비상장\n2017.08.10\n투자\n\xa0 \xa0 \xa0 26,181\n\xa0-\n\xa0 \xa0 \xa0 \xa0 \xa0 100\n\xa0 \xa0 \xa0 26,181\n-\n-\n-\n\xa0-\n\xa0 \xa0 \xa0 100\n\xa0 \xa0 \xa0 26,181\n48,215\n-33\nDS378WEA LLC\n비상장\n2018.09.04\n투자\n\xa0 \xa0 \xa0 57,033\n\xa0-\n\xa0 \xa0 \xa0 \xa0 \xa0 100\n\xa0 \xa0 \xa0 57,033\n-\n-\n-\n\xa0-\n\xa0 \xa0 \xa0\xa0 100\n\xa0 \xa0 \xa0 57,033\n90,025\n-1,496\nInvest400MA LLC\n비상장\n2018.09.11\n투자\n\xa0 \xa0 \xa0 66,862\n\xa0-\n\xa0 \xa0 \xa0 \xa0 \xa0 100\n80,103\n-\n-\n-\n\xa0-\n\xa0 \xa0 \xa0 \xa0 \xa0 100\n80,103\n103,469\n-2,112\nDS Nihonbash East GK\n비상장\n2019.08.26\n투자\n\xa0 \xa0 \xa0 \xa0 8,663\n\xa0-\n100\n8,663\n-\n-8,663\n-\n-\n-\n-\n7,863\n-24\nDS Toranomon GK\n비상장\n2019.10.21\n투자\n\xa0 \xa0 \xa0 46,999\n\xa0-\n\xa099\n\xa046,999\n-\n-\n-\n\xa0-\n\xa099\n\xa046,999\n107,965\n1,076\n대신흥국 PEF\n비상장\n2010.05.25\n투자\n\xa0 \xa0 \xa0\xa0 5,250\n2\n\xa0 \xa0 \xa0 \xa0 \xa0 \xa0 17\n3,780\n-2\n-3,780\n-\n-\n-\n-\n13,059\n-206\n코에프씨대신아주아이비\n비상장\n2011.08.16\n투자\n\xa0 \xa0 \xa0\xa0 1,290\n\xa0 \xa0 3\n14\n3,058\n-\n-202\n-770\n\xa0 \xa0 3\n14\n2,086\n12,639\n-191\n대신-에스케이에스세컨더리\n비상장\n2016.12.28\n투자\n\xa0 \xa0 \xa0 \xa0 \xa0 377\n4,760,390\n5\n4,760\n-\n-\n-\n4,760,390\n5\n4,760\n105,990\n8,220\n대신-코인베스트먼트\n비상장\n2017.09.14\n투자\n\xa0 \xa0 \xa0 \xa0 6,787\n15,558,397\n\xa0 \xa0 \xa0 18\n15,558\n12,254,040\n12,254\n-\n27,812,437\n\xa0 \xa0 \xa0 18\n27,812\n83,509\n-2,247\n합 계\n20,677,491\n-\n1,225,534\n12,259,577\n96,170\n12,180\n32,937,660\n-\n1,333,884\n81,537,616\n458,550\n주\xa01. 기초 또는 기말 현재 해당 법인에 대한 출자비율이 5%를 초과하거나 장부가액이 1억원을 초과하는\xa0 \xa0 \xa0 \xa0 경우 기재하였습니다.\xa0\xa0 \xa0 \xa0\xa02. 최근사업연도 재무현황은\xa02020.12.31\xa0기준으로\xa0작성되었습니다.\xa0 \xa0\xa03. 브릿지바이오테라퓨틱스의 경우, 환매청구권 행사에 따른 인수분을 기재하였으며 무상증자(신주\xa0 \xa0 \xa0\xa0 배정비율 1:2)로 인하여 2020년 10월 15일 수량이 증가하였습니다.\xa0\xa0 4.\xa0코리아바이오컴페니언1호의\xa0경우, 코리아바이오컴페니언1호를 통한 보령바이오파마의 출자 건이\xa0 \xa0 \xa0 \xa0\xa0 므로 최근 사업연도 재무현황은 보령바이오파마 기준으로 작성하였습니다.\xa0 \xa0\xa0\xa05. 청담글로벌의 경우, 전환사채 투자분이 1억원 을 초과함에 따라 기재하였습니다.\xa0\xa0\xa06. 피에이치파마의 경우, 상환전환우선주 14,899주 / 보통주 9,122주 입니다.\xa0 \xa07. 바이오다인의 경우, 2021년 3월 상장에 따른 의무인수분이 발생하여 증가내역을 포함하였으며, \xa0 \xa0 \xa0\xa0 7월 1일 기준, 전량 매도 완료 하였습니다.\xa0\xa0 \xa08.\xa0광주방송\xa0656,000주는\xa0사채지급보증대지급금과 관련하여\xa0채무자로부터\xa0담보물 처분에 따른 취득\xa0 \xa0 \xa0 \xa0 이며 취득가액은 독립적인 외부평가기관인 NICE피앤아이㈜에서 공정가치로 평가하였습니다.\xa0\xa0\xa09. 당기 중 감액된 대신신기술투자조합제2호는 출자 시 외부평가기관의 평가를 받은 사항이 없습니다.\xa010. 핀텔의 경우, 전환사채 투자분이 1억원 을 초과함에 따라 기재하였습니다.\xa011. 대신-에스케이세컨더리, 대신-코인베스트먼트는 당사가 LP로 참여하는 PEF로써, 당기 중 평가\xa0 \xa0 \xa0 손익은 당사의 지분법 손익을 기재 하였습니다. \xa012. 애드바이오텍의 경우 무상증자에 따라 2021년 6월 16일 91,624주 증가함에 따라\xa0 총 보유주식이 \xa0 \xa0 \xa0 137,436주로 변경되었습니다.\xa0\xa0\xa013. 핑거 39,000주, 레인보우로보틱스 39,750주에 대해 당반기 중 취득과 처분이 이루어졌습니다. \xa014. 대신흥국 PEF의 경우, 2021.4.30일자로 청산되었습니다. \xa0\n']"
